-- CStone Pharmaceuticals (HKG:2616) completed a share offering to raise about HK$1.05 billion in net proceeds, according to a Wednesday Hong Kong bourse filing.
Shares of the company fell nearly 3% in late morning trade Thursday.
The pharmaceutical firm placed 118 million new shares at HK$8.97 each to at least six independent investors.
The placing shares represent about 7.40% of the company's enlarged issued share capital.
Net proceeds will be used mainly for research and development of its oncology pipeline, with the remainder for general corporate purposes.